Tumors of ampulla of Vater: A case series and review of chemotherapy options

doi:10.4251/wjgo.v4.i3.60

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6842)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-3) series.

Item

Count

PDF

540

HTML

6053

Tables (1-3)

249

Sum=6842

Mar 15, 2012 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (33)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastrointest Oncol. Mar 15, 2012; 4(3): 60-67
Published online Mar 15, 2012. doi: 10.4251/wjgo.v4.i3.60

Table 1 Demographics, histological features, stage, treatment received and outcome of 20 cases of ampullary carcinoma

No.	Age (yr)	Gender	PS	Tumor subtype	Grade	Stage	Adjuvant therapy	Site of failure	First Line Therapy	Response	TTP (mo)	Status	OS (mo)
1	77	F	1	Intestinal	G2	LD	Op + 5FU-CCRT	NA	NA	NA	NA	DOD	14
2	63	M	0	Intestinal	G3	LD	Op + FOLFOX	-----	-----	-----	-----	NED	17
3	45	M	0	Pancreatobiliary	G2	LD	Op + 5FU-CCRT	NA	NA	NA	NA	DOD	48
4	70	M	1	Intestinal	G2	LD	Op	Lymphnodes	CDDP-Gem	PD	11	DOD	20
5	73	F	0	Intestinal	G1	LD	Op	-----		-----	-----	NED	57
6	60	M	1	Intestinal	G2	LD	Op + 5FU-FA	-----	-----	-----	-----	DOO	36
7	73	M	0	Pancreatobiliary	-----	ED		Peritoneal	Gem-Cap	PD	3	DOD	4
8	79	F	2	Pancreatobiliary	-----	LD	Op + Cap-CCRT	-----	-----	-----	-----	NED	22
9	68	F	0	Pancreatobiliary	G2	LD	Op	-----	-----	-----	-----	NED	219
10	83	F	0	Intestinal	G2	LD	Op	-----	-----	-----	-----	NED	41
11	65	M	2	Neuroendocrine	G4	LD	Op + CDDP-VP16	Liver	Topotecan	PD	2	DOD	10
12	68	M	0	Intestinal	G3	LD	Op + FOLFOX	-----	-----	-----	-----	NED	22
13	48	F	1	Intestinal	G3	LD	Op + 5FU-CCRT	Lung	Gem-Oxa	PD	2	DOD	23
14	49	F	1	Intestinal	G1	LD	Op + Cap-CCRT	-----	-----	-----	-----	NED	24
15	71	F	1	Pancreatobiliary	G1	LD	Op	-----	-----	-----	-----	NED	44
16	61	M	0	Pancreatobiliary	G1	LD	Op + Gem + RT	Multiple	5FU	PD	12	DOD	16
17	65	F	2	Intestinal	G3	LD	Op + FOLFOX	Liver	Gem	PD	14	DOD	19
18	79	M	2	Pancreatobiliary	G3	LD	Op	Liver	NA	PD	4	LOF	-----
19	45	F	0	Pancreatobiliary	G3	LD	Op + 5FU-CCRT	Lung	Gem-Oxa	PD	4	DOD	10
20	33	F	0	Intestinal	G1	LD	Op + Cap-CCRT	-----	-----	-----	-----	NED	30

PS: ECOG Performance status; TTP: Time to progression; LD: Limited disease; ED: Extended disease; Op: Operation; CCRT: Concurrent chemoradiotherapy; 5FU: 5-fluorouracil; FA: Folinic acid; OXA: Oxaliplatin; FOLFOX: 5FU + FA + OXA; Cap: Capecitabine; CDDP; Cisplatin; VP16: Etoposide; Gem: Gemcitabine; NA: Not applicable; PD: Progressive disease; DOD: Died of disease; NED: No evidence of disease; DOO: Died of other cause; LOF: Lost of follow-up; OS: Overall survival.

Citation: Romiti A, Barucca V, Zullo A, Sarcina I, Di Rocco R, D’Antonio C, Latorre M, Marchetti P. Tumors of ampulla of Vater: A case series and review of chemotherapy options. World J Gastrointest Oncol 2012; 4(3): 60-67
URL: https://www.wjgnet.com/1948-5204/full/v4/i3/60.htm
DOI: https://dx.doi.org/10.4251/wjgo.v4.i3.60